Glutamic acid decarboxylase65 (GAD65) antibodies and insulin auto- antibodies in Japanese patients with noninsulin-dependent diabetes mellitus [3]

Endocrine Journal

Volumn 44, Issue 1, 1997, Pages 43-51

  Maruyama, Taro ^a   Kasuga, Akira ^b   Ozawa, Yukako ^b   Nagata, Atsuo ^c   Abiko, Fumi ^c   Suzuki, Yutaka ^a   Saruta, Takao ^b  

^a Social Insurance Saitama Chuo Hosp   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c YAMASA CORPORATION   (Japan)

Author keywords

Autoimmunity; Glutamic acid decarboxylase (GAD); IDDM; Insulin auto antibodies (IAA); NIDDM

Indexed keywords

C PEPTIDE; GLUTAMATE DECARBOXYLASE; INSULIN; INSULIN ANTIBODY; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET THERAPY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PREDICTION; RADIOIMMUNOASSAY;

EID: 0030891562     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.44.43     Document Type: Article

References (30)

1. Olansky L, Welling C, Giddings S, Adler S, Bourey R, Dowse G, Serjeanston S, Zimmet P, Permutt MA (1992) A variant insulin promoter in non-insulin-dependent diabetes mellitus. J Clin Invest 89: 1596-1602.
2. Yoshimasa, Y, Seino S, Whittaker J, Kakehi T, Kosaki A, Kuzuya H, Imura H, Bell GI, Steiner DF (1986) Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. Science 240: 784-787.
3. Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H, Beitz L, McKeon C, Taylor SI (1986) Two mutant alleles of the insulin receptor gene in a patient with extream insulin resistance. Science 240: 787-790.
4. Frouguel Ph, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO, Lesage S, Vinnet N, Clement K, Fougerousse F, Tanizawa Y, Weissenbach J, Beckmann JS, Lathrop GM, Passa Ph, Permutt MA, Cohen D (1992) Close linkage of glucokinase locus on chromosome 7p to early onset non-insulin-dependent diabetes mellitus. Nature 356: 162-164.
5. Reardon W, Ross RJM, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC (1992) Diabetes associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340: 1376-1379.
6. Lebovitz HE (1994) Oral antidiabetic agents. In: Kahn CR, Weir GC (eds) Joslin's Diabetes Mellitus. 13th ed, Malvern, Lea and Febiger: 515-516.
7. Groop LC, Bottazzo GF, Doniach D (1986) Islet cell antibodies identify latent Typel diabetes in aged 35-75 years at diagnosis. Diabetes 35: 237-241.
8. Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K (1987) Time course of islet cell antibodies and beta cell function in non-insulin-dependent stage of Type 1 diabetes. Diabetes 36: 510-517.
9. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR (1993) Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42: 359-362.
10. Atkinson MA, Maclaren NK(1994) The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331: 1428-1436.
11. Ziegler AG, Raymonde DH, Jakson R, Soeldner JS, Eisenbarth GS (1990) Predicting Type 1 Diabetes. Diabetes Care 13: 762-775.
12. Palmer JP (1993) Predicting IDDM. Diabetes Review 1: 104-115.
13. Bingley PJ, Bonifacio E, Gale EAM (1993) Can we predict IDDM? Diabetes 42: 213-220.
14. Gottsaeter A, Lernmark Å, Landin-Olsson M, Sundkvist G, Fernlund P(1993) β-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16: 902-910.
15. Landin-Olsson M, Nilsson KO, Lernmark Å, Sundkvist G (1990) Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 33: 561-568.
16. Maruyama T, Shimada A, Kasuga A, Kasatani T, Ozawa Y, Ishii M, Takei I, Suzuki Y, Kobayashi A, Takeda S, Matsubara K, Saruta T (1994) Analysis of MHC Class II antigens in Japanese IDDM by a novel HLA-typing method, hybridization protection assay. Diabetes Research and Clinical Practice 23: 77-84.
17. Kobayashi T, Takemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K(1993) Immunogenetic and characterization of slowly progressive IDDM. Diabetes Care 16: 780-788.
18. World Health Organization (1985) Diabetes mellitus: Report of a WHO study group. World health organization, Geneva (Techinical report series 727).
19. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T, Ozawa Y, Kasatani T, Saruta T, Li L, Lernmark Å (1994) Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamate decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 19: 113-125.
20. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark Å (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoformspecific glutamic acid decarboxylase antibodies in childhood type 1 diabetes. Diabetologia 37: 314-350.
21. 3H recombinant human ligands. J Immunol Methods 186: 89-99.
22. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, Barmeier H, Mathewes S, Grant FJ, Foster D, Lernmark Å (1991) Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 88: 8337-8341.
23. Kasuga A, Maruyama T, Ozawa Y, Takei I, Falorni A, Lernmark A, Saruta T, (1996) Antibody to the Mr 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese. J Autoimmnity 9: 105-111.
24. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC, participating laboratories (1994) High level of concordance between assays for glutamic acid decarboxylase antibodies: The first International Glutamic Acid Decarboxylase Antibody Worlshop. Diabetes 43: 1005-1009.
25. Vardi P, Dib SA, Tuttleman M, Connelly JE, Grinbergs M, Radizabeth A, Riley WJ, Maclaren NK, Eisenbarth GS, Soeldner JS (1987) Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of Type 1 diabetes mellitus. Diabetes 36: 1286-1291.
26. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA (1994) Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic Medicine 11: 299-303.
27. Hagopian WA, Karlsen AE, Gottsaeter A, Landin-Olsson ML, Grubin CE, Sundkivst G, Petersen JS, Boel E, Dyrberg T, Lernmark A (1993) Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91: 368-374.
28. Niskanen LK, Tuomi T, Karjalainen LC, Groop LC, Uusitupa MIJ (1995) GAD antibodies in NIDDM: Ten-year follow-up from the diagnosis. Diabetes Care 18: 1557-1565.
29. Maruyama T, Kasuga K, Ozawa Y, Matubara T, Takei I, Suzuki Y, Saruta T (1994) The relationship of glutamic acid decarboxylase (GAD)65 antibodies and insulin autoantibodies in Japanese patients with diabetes mellitus. International Symposium of Type 1 (insulin-dependent) diabetes. Nagasaki, Japan, November 12-14, 1994 (abstract).
30. Bingly PJ, Christie MR, Bonifacio E, Bonifacio R, Shattock M, Fonte M-T, Bottazzo GF, Gale EAM (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43: 1304-1310.